title: [Therapeutic indications in herpes zoster].
abstract: Fifty-two patients with acute Herpes Zoster were divided into two groups and treated respectively as follows: 25 received i.v. acyclovir and 27 received s.c. thymopentin, an immunomodulating drug. Both drugs proved effective in promoting the recovery from herpetic lesions and in relieving the painful symptomatology within approximately the same period of time. Thymopentin apparently has an antiphlogistic effect and is believed to prevent post-herpetic neuropathy through its immunomodulating activity. Further studies based on a larger number of patients would be necessary to confirm the results achieved and for statistical evaluation.
authors.affiliation: Divisione Malattie Infettive, U.S.S.L. 45, Ospedale Provinciale S. Andrea, Vercelli.
authors.forename: F
authors.initials: F
authors.lastname: Carcò
authors.forename: C
authors.initials: C
authors.lastname: Gili
authors.forename: M
authors.initials: M
authors.lastname: Gobber
authors.forename: B
authors.initials: B
authors.lastname: Bianchi
authors.forename: G
authors.initials: G
authors.lastname: Guazzotti
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016305:Thymopentin / Q000627:therapeutic use*
chemical_list: D016305:Thymopentin; D000212:Acyclovir
vernacular_title: Indicazioni terapeutiche nell'herpes zoster.